missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human KIAA1429 (aa 1049-1146) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56772 (PA5-56772. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
KIAA1429 is required for N6-methyladenosine (m6A) methylation of mRNAs, a modification that plays a role in the efficiency of mRNA splicing and processing. It is also Involved in mRNA splicing regulation, probably via its function in m6A methylation. Diseases associated with KIAA1429 include Retinitis Pigmentosa 42.
Specifications
Specifications
| Accession Number | Q69YN4 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 25962 |
| Name | Human KIAA1429 (aa 1049-1146) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1110037F02Rik; 4930422M05Rik; DKFZP434I116; fSAP121; functional spliceosome-associated protein 121; KIAA1429; mKIAA1429; MSTP054; protein virilizer homolog; RGD1559904; RIKEN cDNA 1110037F02 gene; similar to mKIAA1429 protein; Virma |
| Common Name | KIAA1429 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction